<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182023000100013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectividad del Heberferon en el tratamiento del carcinoma basocelular]]></article-title>
<article-title xml:lang="en"><![CDATA[Effectiveness of Heberferon in the treatment of basal cell carcinoma]]></article-title>
<article-title xml:lang="pt"><![CDATA[Eficácia do Heberferon no tratamento do carcinoma basocelular]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Rosales]]></surname>
<given-names><![CDATA[Solem]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fonseca Núñez]]></surname>
<given-names><![CDATA[Yuduanis Dailín]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fuentes Gómez]]></surname>
<given-names><![CDATA[Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mojena Hernández]]></surname>
<given-names><![CDATA[Dayamí Lorenza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tamayo Ladrón de Guevara]]></surname>
<given-names><![CDATA[Amarilys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Policlínico Docente 13 de Marzo ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital General Universitario Carlos Manuel de Céspedes  ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Policlínico Docente Bayamo Oeste  ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital General Luis Ángel Milanés  ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>27</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182023000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182023000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182023000100013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El Carcinoma basocelular es el cáncer de piel más frecuente en el ser humano, representa aproximadamente entre un 70 y un 80 % de los cánceres cutáneos no melanoma en la población de color de piel blanca, este es un tumor maligno de estirpe epitelial y es el más frecuente en la consulta dermatológica, soliendo afectar a individuos mayores de 50 años con máxima incidencia entre la sexta y octava década de la vida. Se realizó un estudio postcomercialización, observacional, de serie de casos, de vigilancia temprana del medicamento en condiciones de práctica médica habitual. La investigación se ejecutó con los pacientes con diagnóstico de carcinoma basocelular, atendidos en la consulta en la consulta de oncodermatología, que tiene su sede Hospital &#8223;Carlos Manuel de Céspedes&#8221; de Bayamo, durante el período comprendido entre enero 2018 a diciembre 2019.El universo estuvo constituido por 120 pacientes y la muestra por 92 pacientes mayores de 18 años, a los que se les administró HeberFERON, resultando ser efectivo en el tratamiento de carcinoma basocelular de cualquier localización, tipo y tamaño. Se confirmó la efectividad en condiciones de práctica médica habitual, en las variables: respuesta clínica al tratamiento, utilizando para ello, los criterios RECIST, además mostró un perfil de seguridad adecuado. Los eventos adversos reportados fueron en su mayoría grado 1 y grado 2, según la clasificación del CTCAE, versión 5 y por su gravedad, se clasificaron no grave.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Basal cell carcinoma is the most frequent skin cancer in humans, representing approximately between 70 and 80% of non-melanoma skin cancers in the white-skinned population, this is a malignant tumor of epithelial lineage and is the most frequent in dermatological consultation, usually affecting individuals over 50 years of age with maximum incidence between the sixth and eighth decade of life. A post-marketing study was conducted, observational, case series, of early surveillance of the drug under conditions of routine medical practice. The research was carried out with patients diagnosed with basal cell carcinoma, attended in the consultation in the oncodermatology consultation, which has its headquarters Hospital &#8223;Carlos Manuel de Céspedes" of Bayamo, during the period from January 2018 to December 2019. The universe consisted of 120 patients and the sample was 92 patients over 18 years of age, who were administered HeberFERON, proving to be effective in the treatment of basal cell carcinoma of any location, type and size. The effectiveness in conditions of usual medical practice was confirmed, in the variables: clinical response to treatment, using the RECIST criteria, in addition to showing an adequate safety profile. The adverse events reported were mostly grade 1 and grade 2, according to the classification of the CTCAE, version 5 and due to their severity, they were classified as non-serious.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO O carcinoma basocelular é o câncer de pele mais frequente em humanos, representando aproximadamente entre 70 e 80% dos cânceres de pele não melanoma na população de pele branca, sendo este um tumor maligno de linhagem epitelial e o mais frequente na consulta dermatológica, acometendo geralmente indivíduos com mais de 50 anos de idade com incidência máxima entre a sexta e a oitava década de vida. Foi realizado um estudo pós-comercialização, observacional, série de casos, de vigilância precoce da droga sobcondições de prática médica de rotina.A pesquisa foi realizada com pacientes diagnosticados com carcinoma basocelular, atendidos na consulta na consulta de oncodermatologia, que temsua sede no Hospital Carlos Manuel de Céspedes, de Bayamo, no período de janeiro de 2018 a dezembro de 2019. O universo foi composto por 120 pacientes e a amostra foi de 92 pacientes com mais de 18 anos de idade, aos quais foi administrado HeberFERON, mostrando-se eficaz no tratamento do carcinoma basocelular de qualquer localização, tipo e tamanho. A efetividade nas condições de prática médica habitual foi confirmada, nas variáveis: resposta clínica ao tratamento, utilizando-se os critérios RECIST, além de apresentarum perfil de segurança adequado. Os eventos adversos relatados foram, em sua maioria, grau 1 e grau 2, de acordo com a classificação do CTCAE, versão 5 e, devido à sua gravidade, foram classificados como não graves.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Heberferon]]></kwd>
<kwd lng="es"><![CDATA[Efectividad]]></kwd>
<kwd lng="es"><![CDATA[Carcinoma basocelular]]></kwd>
<kwd lng="en"><![CDATA[Heberferon]]></kwd>
<kwd lng="en"><![CDATA[Effectiveness]]></kwd>
<kwd lng="en"><![CDATA[Basal cell carcinoma]]></kwd>
<kwd lng="pt"><![CDATA[Heberferon]]></kwd>
<kwd lng="pt"><![CDATA[Eficácia]]></kwd>
<kwd lng="pt"><![CDATA[Carcinoma basocelular]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bordolois Abdo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[López Mateus]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Ramírez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Lagos Ordoñez]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización del adulto mayor con diagnóstico probable de cáncer de piel]]></article-title>
<source><![CDATA[Rev Inf Científica]]></source>
<year>2019</year>
<volume>98</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-16</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drake-Sosa]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas-Barlys]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HeberFERON en pacientes con carcinoma basocelular tratados en el municipio Puerto Padre, Las Tunas]]></article-title>
<source><![CDATA[Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta]]></source>
<year>2018</year>
<volume>43</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araus Defaz]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
</person-group>
<source><![CDATA[Incidencia de pacientes con carcinoma basocelular entre 45 a 75 años tratados en el hospital general Guasmo Sur de enero a junio del 2018.]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Guayaquil ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Guayaquil]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amaya Nieto]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra Patiño]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Estepa]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización en Carcinoma Basocelular Periocular _ Abordaje Semiológico Y Diagnóstico. Actualización en carcinoma baso celular periocular: abordaje semiológico y diagnóstico diferencial]]></article-title>
<source><![CDATA[Cienc Tecnol Salud Vis Ocul]]></source>
<year>2019</year>
<numero>1</numero>
<issue>1</issue>
<page-range>45-56</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahnlide]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bjellerup]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accuracy of clinical skin tumour diagnosis in a dermatological setting]]></article-title>
<source><![CDATA[Acta Derm Venereol]]></source>
<year>2013</year>
<volume>93</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>305-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Veja Abascal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Fernandez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ventura Nieves]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Hidalgo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nodal Trujillo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento con HeberFERON(r) del carcinoma basocelular en la Atención Primaria de Salud en Cuba]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>2021</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Castillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Alfaro]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Boza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisión sistemática del carcinoma basocelular]]></article-title>
<source><![CDATA[Rev Médica Sinergia]]></source>
<year>2020</year>
<volume>5</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e483-e96</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Infante Carbonel]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[González Calzadilla]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Joen Infante]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Del Valle Piñera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Melanoma cutáneo: algunas consideraciones actuales]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2019</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>146-64</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armas Morell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sotolongo Díaz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectividad del heberferon en el tratamiento del carcinoma baso celular]]></article-title>
<source><![CDATA[Universidad&amp;Ciencia]]></source>
<year>2019</year>
<volume>8</volume>
<numero>XLI</numero>
<issue>XLI</issue>
<page-range>731-41</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tejera-Vaquerizo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Descalzo-Gallego]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Otero-Rivas]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Posada García]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Pazos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pastushenko]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidencia y mortalidad del cáncer cutáneo en España: revisión sistemática y metaanálisis]]></article-title>
<source><![CDATA[Actas Dermosifiliog]]></source>
<year>2016</year>
<volume>107</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>318-28</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marrero-González]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ricardo-Mora]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Hidalgo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Peña-Pérez]]></surname>
<given-names><![CDATA[OR]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Yabor]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efectividad del HeberFERON en el tratamiento del carcinoma basocelular]]></article-title>
<source><![CDATA[Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta]]></source>
<year>2021</year>
<volume>46</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Cuba</collab>
<collab>Ministerio de Salud Pública</collab>
<source><![CDATA[Anuario Estadístico de Salud 2020]]></source>
<year>2021</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cubas Villegas]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[De la Cruz Monteza]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Características epidemiológicas, clínicas e histopatológicas del carcinoma basocelular en pacientes del Hospital Regional de Lambayeque del 2012 al 2018.]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Lambayeque ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional Pedro Ruiz Gall]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Linares]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cifuentes Suarez]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Cuervo]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Román Simón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez García]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bello Rivero]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carcinoma basocelular del rostro tratado con HeberFERON]]></article-title>
<source><![CDATA[Gac Méd Espirit]]></source>
<year>2019</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>87-97</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morales Duarte]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico del carcinoma basocelular pigmentado]]></article-title>
<source><![CDATA[Alerta]]></source>
<year>2020</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Kus]]></surname>
<given-names><![CDATA[KJB]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Basal Cell Carcinoma Review]]></article-title>
<source><![CDATA[Hematol Oncol Clin North Am]]></source>
<year>2019</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-24</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanclemente]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Thomson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intervenciones para el carcinoma basocelular cutáneo (revisión Cochrane): Resumen de las principales comparaciones e interpretación práctica de los resultados]]></article-title>
<source><![CDATA[ACTAS Dermo-Sifiliográficas]]></source>
<year>2023</year>
<volume>114</volume>
<numero>2023</numero>
<issue>2023</issue>
<page-range>39-48</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piña Rodríguez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Monsón Díaz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Piña Russinyol]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Alapon Guillarte]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HeberFERON, experiencia en la provincia de Matanzas]]></article-title>
<source><![CDATA[Folia Dermatológica Cubana]]></source>
<year>2019</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrá-Torres]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Rodríguez]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Ballester-Caballero]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Sallary-Gutiérrez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de pacientes con carcinoma basocelular tratados con HeberFERON]]></article-title>
<source><![CDATA[AMC]]></source>
<year>2020</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
